Pure Global AI
NCT06310161Not yet recruiting

Light Therapy in End Stage Kidney Disease

Bright Light Therapy to Treat Fatigue in End Stage Kidney Disease
University of PennsylvaniaClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
End Stage Renal Disease
Drug/Device/Intervention
Bright light
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Pennsylvania
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2024
End date
Mar 01, 2025
Enrollment
60 participants
Primary outcome

Fatigue Severity Scale

Summary

The goal of this clinical trial is to test light therapy in patients with end stage kidney
 disease who are receiving hemodialysis. The main aim is to determine if light therapy
 decreases fatigue severity. Participants will receive light therapy using special glasses for
 one hour during the dialysis sessions for four weeks of treatment.

ICD-10 classifications
Chronic kidney disease, stage 1Chronic kidney disease, stage 5Chronic kidney disease, stage 2Chronic kidney disease, stage 3Chronic kidney disease, stage 4
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06310161
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06310161 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Pennsylvania and is currently Not yet recruiting. The study focuses on End Stage Renal Disease. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.